Finance

Beta
Lists
VYNE:NASDAQ
Vyne Therapeutics Inc
$0.68
-0.73%
(-0.0050) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VYNE...
Open
$0.68
High
$0.69
Low
$0.67
Mkt. cap
22.64M
Avg. vol.
203.13K
Volume
72.42K
52-wk high
$1.96
52-wk low
$0.28
EPS
-$0.50
Beta
2.00
Shares outstanding
33.35M
No. of employees
10
Open
$0.68
High
$0.69
Low
$0.67
Mkt. cap
22.64M
Avg. vol.
203.13K
Volume
72.42K
52-wk high
$1.96
52-wk low
$0.28
EPS
-$0.50
Beta
2.00
Shares outstanding
33.35M
No. of employees
10
News stories
From sources across the web
About Vyne Therapeutics Inc
CEO-
Employees10
Founded2003
HeadquartersBridgewater, New Jersey, United States
SectorPharmaceutical industry
Websitevynetherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
69.00K
169.00K
130.00K
86.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.88M
5.26M
2.98M
817.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.73M
2.70M
2.37M
3.08M
Operating expense
7.61M
7.96M
5.35M
3.90M
Total operating expenses
7.61M
7.96M
5.35M
3.90M
Operating income
-7.54M
-7.79M
-5.22M
-3.82M
Other non operating income
495.00K
366.00K
-1.45M
231.00K
EBT including unusual items
-5.75M
-7.43M
-4.96M
-3.58M
EBT excluding unusual items
-7.05M
-7.43M
-4.96M
-3.58M
Income tax expense
-
-
4.00K
-
Effective tax rate
-
-
-0.08%
-
Other operating expenses
-
-
-
-
Net income
-5.76M
-7.28M
-4.84M
-3.58M
Net profit margin
-8,340.58%
-4,307.69%
-3,720.77%
-4,168.60%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.72M
-
Interest expense
-
-
-
-
Net interest expenses
-
-
1.72M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.54M
-7.79M
-5.21M
-3.81M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer